Stay updated on Nivolumab and HPV-16 Vaccine for Incurable Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and HPV-16 Vaccine for Incurable Solid Tumors Clinical Trial page.

Latest updates to the Nivolumab and HPV-16 Vaccine for Incurable Solid Tumors Clinical Trial page
- Check3 days agoChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6, indicating a minor update to the page or site. This change reflects versioning rather than substantive content changes to the study details.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedPage revision updated to v3.6.5, replacing v3.6.4. This indicates a minor update to the page software with no changes to the study details or content.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page’s revision label was updated from v3.6.3 to v3.6.4, indicating a deployment or update to the underlying system without altering the displayed study details.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3, signaling a minor software revision. No visible changes to the page content or layout are indicated by the provided data.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page shows Revision: v3.6.2, reflecting a minor software version update to the ClinicalTrials.gov page. This appears to be a backend/UI maintenance change rather than a modification to the study details.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page now includes user-guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and shows that recruitment is closed ('No longer looking for participants'), along with a Revision: v3.6.0. The Intervention/Treatment heading has been reformatted from 'Intervention / Treatment'.SummaryDifference0.4%

Stay in the know with updates to Nivolumab and HPV-16 Vaccine for Incurable Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and HPV-16 Vaccine for Incurable Solid Tumors Clinical Trial page.